288 related articles for article (PubMed ID: 31982550)
1. Modulation of polycystic kidney disease by non-coding RNAs.
Ramalingam H; Yheskel M; Patel V
Cell Signal; 2020 Jul; 71():109548. PubMed ID: 31982550
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic microRNAs in polycystic kidney disease.
Yheskel M; Patel V
Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):282-289. PubMed ID: 28399020
[TBL] [Abstract][Full Text] [Related]
3. Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model.
Dweep H; Sticht C; Kharkar A; Pandey P; Gretz N
PLoS One; 2013; 8(1):e53780. PubMed ID: 23326503
[TBL] [Abstract][Full Text] [Related]
4. Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease.
Pandey P; Qin S; Ho J; Zhou J; Kreidberg JA
BMC Syst Biol; 2011 Apr; 5():56. PubMed ID: 21518438
[TBL] [Abstract][Full Text] [Related]
5. miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.
Patel V; Williams D; Hajarnis S; Hunter R; Pontoglio M; Somlo S; Igarashi P
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10765-70. PubMed ID: 23759744
[TBL] [Abstract][Full Text] [Related]
6. RNA helicase p68 inhibits the transcription and post-transcription of
Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
[No Abstract] [Full Text] [Related]
7. Regulation of KLF12 by microRNA-20b and microRNA-106a in cystogenesis.
Shin Y; Kim DY; Ko JY; Woo YM; Park JH
FASEB J; 2018 Jul; 32(7):3574-3582. PubMed ID: 29475398
[TBL] [Abstract][Full Text] [Related]
8. Non-Coding RNAs in Hereditary Kidney Disorders.
Zhou JX; Li X
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809516
[TBL] [Abstract][Full Text] [Related]
9. Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease.
Lee EC; Valencia T; Allerson C; Schairer A; Flaten A; Yheskel M; Kersjes K; Li J; Gatto S; Takhar M; Lockton S; Pavlicek A; Kim M; Chu T; Soriano R; Davis S; Androsavich JR; Sarwary S; Owen T; Kaplan J; Liu K; Jang G; Neben S; Bentley P; Wright T; Patel V
Nat Commun; 2019 Sep; 10(1):4148. PubMed ID: 31515477
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease.
Lakhia R; Hajarnis S; Williams D; Aboudehen K; Yheskel M; Xing C; Hatley ME; Torres VE; Wallace DP; Patel V
J Am Soc Nephrol; 2016 Aug; 27(8):2319-30. PubMed ID: 26677864
[TBL] [Abstract][Full Text] [Related]
11. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
Kurbegovic A; Trudel M
Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315
[TBL] [Abstract][Full Text] [Related]
12. Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.
Lakhia R; Yheskel M; Flaten A; Ramalingam H; Aboudehen K; Ferrè S; Biggers L; Mishra A; Chaney C; Wallace DP; Carroll T; Igarashi P; Patel V
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32182218
[TBL] [Abstract][Full Text] [Related]
13. microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism.
Hajarnis S; Lakhia R; Yheskel M; Williams D; Sorourian M; Liu X; Aboudehen K; Zhang S; Kersjes K; Galasso R; Li J; Kaimal V; Lockton S; Davis S; Flaten A; Johnson JA; Holland WL; Kusminski CM; Scherer PE; Harris PC; Trudel M; Wallace DP; Igarashi P; Lee EC; Androsavich JR; Patel V
Nat Commun; 2017 Feb; 8():14395. PubMed ID: 28205547
[TBL] [Abstract][Full Text] [Related]
14. Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline.
Ben-Dov IZ; Tan YC; Morozov P; Wilson PD; Rennert H; Blumenfeld JD; Tuschl T
PLoS One; 2014; 9(1):e86856. PubMed ID: 24489795
[TBL] [Abstract][Full Text] [Related]
15. Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease.
Ali H; Malik MZ; Abu-Farha M; Abubaker J; Cherian P; Nizam R; Jacob S; Bahbahani Y; Naim M; Ahmad S; Al-Sayegh M; Thanaraj TA; Ong ACM; Harris PC; Al-Mulla F
J Gene Med; 2024 Feb; 26(2):e3674. PubMed ID: 38404150
[TBL] [Abstract][Full Text] [Related]
16. Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth.
Yheskel M; Lakhia R; Cobo-Stark P; Flaten A; Patel V
Sci Rep; 2019 Feb; 9(1):1920. PubMed ID: 30760828
[TBL] [Abstract][Full Text] [Related]
17. Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for autosomal dominant polycystic kidney disease.
Magayr TA; Song X; Streets AJ; Vergoz L; Chang L; Valluru MK; Yap HL; Lannoy M; Haghighi A; Simms RJ; Tam FWK; Pei Y; Ong ACM
Kidney Int; 2020 Aug; 98(2):420-435. PubMed ID: 32622528
[TBL] [Abstract][Full Text] [Related]
18. Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.
Kim DY; Woo YM; Lee S; Oh S; Shin Y; Shin JO; Park EY; Ko JY; Lee EJ; Bok J; Yoo KH; Park JH
FASEB J; 2019 Feb; 33(2):2870-2884. PubMed ID: 30332302
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease.
Zheng Q; Reid G; Eccles MR; Stayner C
Front Physiol; 2022; 13():1006427. PubMed ID: 36203940
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
